Skip to main content

Advertisement

SpringerLink
Log in

Epidemiology and Microbiology of Nosocomial Pediatric Candidemia at a Northern Indian Tertiary Care Hospital

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

The availability and aggressive use of chemotherapeutic and immunosuppressive agents as well as broad-spectrum antibacterial agents have created a large population of patients who are at increased risk of acquiring infections with fungal organisms, especially Candida species. Present work was undertaken to study the epidemiology and microbiology of candidemia and Candida colonization in hospitalized children. A total of 323 suspected cases of septicemia were enrolled, of which blood culture from 7.4% subjects was positive for Candida species. In total, 57.3% subjects were colonized by Candida species at least at one of the tested sites. Of 337 isolates, 24.3, 71.5, 2.9, 0.59, and 0.59% were Candida albicans, Candida tropicalis, Candida krusei, Candida kefyr, and Candida lusitaniae, respectively. Antifungal susceptibility results show that fluconazole, itraconazole, and amphotericin B resistance is prevalent in 18.2, 2.4, and 3.6% of C. albicans isolates, and 21.1, 4.6, and 0.04% of C. tropicalis isolates, respectively. In a large number of cases, source of blood infection was patient’s own colonizers, as shown by genetic matching. It was also noted that some strain types are circulating within the ward. High prevalence of non-albicans candidemia with high resistance to fluconazole is prevalent in North Indian hospitalized children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Chang A, Neofytos D, Horn D. Candidemia in the 21st century. Futur Microbiol. 2008;3(4):463–72.

    Article  CAS  Google Scholar 

  2. Hazen KC. New and emerging yeast pathogens. Clin Microbiol Rev. 1995;8(4):462–78.

    PubMed  CAS  Google Scholar 

  3. Beck-Sague CM, Jarvis WR. The National Nosocomial Surveillance System. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. J Infect Dis. 1993;167(5):1247–51.

    Article  PubMed  CAS  Google Scholar 

  4. Milne L J R. Fungi. In: Collee JG, Fraser AG, Marmion BP, et al. editors. Mackie and McCartney practical medical microbiology, 14th edn. London: Churchill Livingstone; 1996. p. 695–717.

  5. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med. 1977;296(23):1305–9.

    Article  PubMed  CAS  Google Scholar 

  6. Warren MG, Roberts GD, Hazen KC: Candida, Cryptococcus, and other yeasts of medical importance In: Murry PR, Baron EJ, Pfaller MA, et al. editors. Manual of clinical microbiology, Sixth Edition. Washington, DC: ASM Press; 1995. p. 723–37.

  7. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard 2nd edn. Wayne, PA: National Committee for Clinical Laboratory Standards; 2002. Clinical and Laboratory Standards Institute document M27-A2.

  8. Barry AL, Pfaller MA, Brown SD, Espinel-Ingroff A, et al. Quality control limits for broth microdilution susceptibility tests of ten antifungal agents. J Clin Microbiol. 2000;38(9):3457–9.

    PubMed  CAS  Google Scholar 

  9. Williams JKG, Kubelik AR, Livak KJ, Rafalski JA, Tingey SV. DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nucleic Acids Res. 1990;18(22):6531–5.

    Article  PubMed  CAS  Google Scholar 

  10. Lehmann PF, Lin D, Lasker BA. Genotypic identification and characterization of species and strains within the genus Candida by using random amplified polymorphic DNA. J Clin Microbiol. 1992;30(12):3249–54.

    PubMed  CAS  Google Scholar 

  11. Babay HA, Twum-Danso K, Kambal AM, Al-Otaibi FE. Bloodstream infections in pediatric patients. Saudi Med J. 2005;26(10):1555–61.

    PubMed  Google Scholar 

  12. Viudes A, Pemán J, Cantón E, Ubeda P, López-Ribot JL, Gobernado M. Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur J Clin Microbiol Infect Dis. 2002;21(11):767–74.

    Article  PubMed  CAS  Google Scholar 

  13. Neu N, Malik M, Lunding A, Whittier S, Alba L, Kubin C, Saiman L. Epidemiology of candidemia at a children’s hospital, 2002 to 2006. Pediatr Infect Dis J. 2009;28(9):806–9.

    Article  PubMed  Google Scholar 

  14. MacDonald L, Baker C, Chenoweth C. Risk factors for candidemia in a children’s hospital. Clin Infect Dis. 1998;26(3):642–5.

    Article  PubMed  CAS  Google Scholar 

  15. Singhi S, Rao DS, Raman V, Chakrabarti A. Candida colonization and candidemia in a pediatric intensive care unit. Pedia Crit Care Med. 2008;9(1):91–5.

    Article  Google Scholar 

  16. Singh K, Chakrabarti A, Narang A, et al. Yeast colonization and fungemia in preterm neonates in a tertiary care center. Ind J Med Res. 1999;110:169–73.

    CAS  Google Scholar 

  17. Samonis G, Gikas A, Toloudis P, et al. Prospective study of the impact of broad spectrum antibiotics on the yeast flora of the human gut. Eur J Clin Microbiol Infect Dis. 1994;13(8):665–7.

    Article  PubMed  CAS  Google Scholar 

  18. Petri MG, Konig J, Moecke HP, et al. Epidemiology of invasive mycosis in ICU patients epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich society for chemotherapy, divisions of mycology and pneumonia research. Intensive Care Med. 1997;23(3):317–25.

    Article  PubMed  CAS  Google Scholar 

  19. Abelson JA, Moore T, Bruckner D, Deville J, Nielsen K. Frequency of fungemia in hospitalized pediatric inpatients over 11 years at a tertiary care institution. Pediatrics. 2005;116(1):61–7.

    Article  PubMed  Google Scholar 

  20. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg. 1994;220(6):751–8.

    Article  PubMed  CAS  Google Scholar 

  21. Almirante B, Rodríguez D, Cuenca-Estrella M, Almela M, Sanchez F, Ayats J, et al. Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol. 2006;44(5):1681–5.

    Article  PubMed  Google Scholar 

  22. Richet HM, Andremont A, Tancrede C, Pico JL, Jarvis WR. Risk factors for candidemia in patients with acute lymphocytic leukemia. Rev Infect Dis. 1991;13(2):211–5.

    Article  PubMed  CAS  Google Scholar 

  23. Nucci M, Anaissie E. Revisiting the source of candidemia: skin or gut? Clin Infect Dis. 2001;33(12):1959–67.

    Article  PubMed  CAS  Google Scholar 

  24. Charles PE, Dalle F, Aube H, Doise JM, Quenot JP, Aho LS, Chavanet P, Blettery B. Candida species colonization significance in critically ill medical patients: a prospective study. Intensive Care Med. 2005;31(3):393–400.

    Article  PubMed  Google Scholar 

  25. Martín E, Parras P, Lozano MC. In vitro Susceptibility of 245 Yeast Isolates to Amphotericin B, 5-Fluorocytosine, Ketoconazole, Fluconazole and Itraconazole. Chemotherapy. 1992;38(5):335–9.

    Article  PubMed  Google Scholar 

  26. Blyth CC, Chen SC, Slavin MA, Serena C, Nguyen Q, Marriott D, Ellis D, Meyer W, Sorrell TC. Australian Candidemia study. Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics. 2009;123(5):1360–8.

    Article  PubMed  Google Scholar 

  27. Saha R, Shukla DD, Kumar A, Kaur IR. Pattern of Candida isolates in hospitalized children. Indian J Pediatr. 2008;75(8):858–60.

    Article  PubMed  Google Scholar 

  28. Agarwal J, Bansal S, Malik GK, Jain A. Trends in neonatal septicemia: emergence of non-albicans Candida. Indian Pediatr. 2004;41(7):712–5.

    PubMed  Google Scholar 

  29. Jain A, Awasthi AK, Kumar M. Etiological and anti-microbial susceptibility profile of nosocomial blood stream infections (NBSI) in neonatal intensive care unit (NICU). Indian J Med Micro. 2007;25(3):299–300.

    Article  CAS  Google Scholar 

  30. Price MF, Larocco MT, Gentrry LO. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5 years period. Antimicro Agents Chemo. 1994;38(6):1422–4.

    CAS  Google Scholar 

  31. Zaoutis TE, Foraker E, McGowan KL, Mortensen J, Campos J, Walsh TJ, Klein JD. Antifungal susceptibility of Candida species isolated from pediatric patients: a survey of 4 children’s hospitals. Diagn Microbiol Infect Dis. 2005;52(4):295–8.

    Article  PubMed  CAS  Google Scholar 

  32. Cuenca-Estrella M, Rodero L, García-Effrón G, Rodriguez-Tudela JL. Antifungal susceptibilities of Candida species isolated from blood in Spain and Argentina, 1996–1999. J Antimicrob Chemo. 2002;49(6):981–7.

    Article  CAS  Google Scholar 

  33. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of Hematogenous Candidiasis caused by Candida species. Clin Infect Dis. 1997;24(6):1122–8.

    Article  PubMed  CAS  Google Scholar 

  34. Narain S, Shastri JS, Mathur M, Mehta PR. Neonatal systemic candidiasis in a tertiary care centre. Indian J Med Microbiol. 2003;21(1):56–8.

    PubMed  CAS  Google Scholar 

  35. Narang A, Agarwal PR, Chakrabarti A, Kumar P. Epidemiology of systemic candidiasis in a tertiary care neonatal unit. J Trop Pedia. 1998;44(2):104–8.

    Article  CAS  Google Scholar 

  36. Borg-von Zepelin M, Kunz L, Rüchel R, Reichard U, Weig M, Gross U. Epidemiology and antifungal susceptibilities of Candida species to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005. J Antimicrob Chemother. 2007;60(2):424–8.

    Article  PubMed  CAS  Google Scholar 

  37. Giusiano G, Mangiaterra M, Garcia Saito V, Rojas F, Gómez V, Díaz MC. Fluconazole and itraconazole resistance of yeasts isolated from the bloodstream and catheters of hospitalized pediatric patients. Chemotherapy. 2006;52(5):254–9.

    Article  PubMed  CAS  Google Scholar 

  38. Foongladda S, Sakulmaiwatana P, Petlum P, Vanprapar N. Candida species, genotypes and antifungal susceptibility of Candida isolates from blood samples of patients at the largest tertiary care hospital in Thailand during 1999–2002. J Med Assoc Thai. 2004;87(1):92–9.

    PubMed  Google Scholar 

  39. Hajjeh RA, Sofair AN, Harrison IH, Lyon GM, Arthington-Skaggs BA, Mirza SA, et al. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol. 2004;42(4):1519–27.

    Article  PubMed  Google Scholar 

  40. Yang YL, Cheng HH, Lo HJ. Tsary hospitals. Distribution and antifungal susceptibility of Candida species isolated from different age populations in Taiwan. Med Mycol. 2006;44(3):237–42.

    Article  PubMed  CAS  Google Scholar 

  41. Hernández-Dueñas AM, Vázquez-Larios Mdel R, Soto-Nieto GI, Rivera-Martínez E. Yeast susceptibility isolated from blood cultures of patients at the National Cardiology Institute Ignacio Chávez. Rev Invest Clin. 2009;61(4):294–9.

    PubMed  Google Scholar 

  42. González GM, Elizondo M, Ayala J. Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-years (2004 to 2007) surveillance study. J Clin Microbiol. 2008;46(9):2902–5.

    Article  PubMed  Google Scholar 

  43. Espinel-Ingroff A. Mechanisms of resistance to antifungal agents: yeasts and filamentous fungi. Rev Iberoam Micol. 2008;25(2):101–6.

    Article  PubMed  Google Scholar 

  44. Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev. 1996;9(4):499–511.

    PubMed  CAS  Google Scholar 

  45. Jordan JA. PCR identification of four medically important Candida species by using a single primer pair. J Clin Micro. 1994;32(12):2962–7.

    CAS  Google Scholar 

  46. Robert F, Lebreton F, Bougnoux ME, Paugam A, Wassermann D, Schlotterer M, et al. Use of random amplified polymorphic DNA as a typing method for Candida albicans in epidemiological surveillance of a burn unit. J Clin Microbiol. 1995;33(9):2366–71.

    PubMed  CAS  Google Scholar 

  47. Roilides E, Farmaki E, Evdoridou J, Francesconi A, Kasai M, et al. Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen. J Clin Microbiol. 2003;41(2):735–41.

    Article  PubMed  Google Scholar 

  48. Pinto PM, Resende MA, Koga-Ito CY, Tendler M. Genetic variability analysis among clinical Candida species isolates using random amplified polymorphic DNA. Mem Inst Oswaldo Cruz. 2004;99(2):147–52.

    Article  PubMed  CAS  Google Scholar 

  49. Marol S, Yücesoy M. Molecular epidemiology of Candida species isolated from clinical specimens of intensive care unit patients. Mycoses. 2008;51(1):40–9.

    PubMed  CAS  Google Scholar 

  50. Vrioni G, Matsiota-Bernard P. Molecular typing of Candida isolates from patients hospitalized in an intensive care unit. J Infect. 2001;42(1):50–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by International Clinical Epidemiology Network (INCLEN) through The United States Agency for International Development’s (USAID).

Conflict of Interest

None.

Author information

Authors and Affiliations

  1. Department of Microbiology, Chhatrapati Shahuji Maharaj Medical University (Erstwhile King George’s Medical University), Lucknow, Uttar Pradesh, 226 003, India

    Avijit Kumar Awasthi & Amita Jain

  2. Department of Pediatrics, Chhatrapati Shahuji Maharaj Medical University (Erstwhile King George’s Medical University), Lucknow, Uttar Pradesh, 226 003, India

    Shally Awasthi & Ankur Ambast

  3. Institute of Clinical Epidemiology, Chhatrapati Shahuji Maharaj Medical University (Erstwhile King George’s Medical University), Lucknow, Uttar Pradesh, 226 003, India

    Kamlesh Singh

  4. Department of Microbiology, Bundelkhand University, Jhansi, Uttar Pradesh, 284128, India

    Vijendra Mishra

Authors
  1. Avijit Kumar Awasthi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amita Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shally Awasthi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ankur Ambast
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kamlesh Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Vijendra Mishra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amita Jain.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Awasthi, A.K., Jain, A., Awasthi, S. et al. Epidemiology and Microbiology of Nosocomial Pediatric Candidemia at a Northern Indian Tertiary Care Hospital. Mycopathologia 172, 269–277 (2011). https://doi.org/10.1007/s11046-011-9431-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-011-9431-9

Keywords

Search

Navigation